Artesunate Protects Against Sepsis-Induced Lung Injury Via Heme Oxygenase-1 Modulation

Male 0303 health sciences Interleukin-6 NF-E2-Related Factor 2 Acute Lung Injury Anti-Inflammatory Agents NF-kappa B Artesunate Nitric Oxide Synthase Type II Protoporphyrins Artemisinins 3. Good health Enzyme Activation Mice 03 medical and health sciences Neutrophil Infiltration Cyclooxygenase 2 Sepsis Animals Bronchoalveolar Lavage Fluid Cecum Lung Heme Oxygenase-1
DOI: 10.1007/s10753-015-0290-2 Publication Date: 2015-12-01T05:09:48Z
ABSTRACT
Artesunate, a derivative of artemisinin, has anti-inflammatory properties and exerts protective roles in sepsis. Heme oxygense-1 (HO-1) inhibits the inflammatory response through reduction of proinflammatory cytokines and leukocyte influx into tissues. The present study investigated the effects of artesunate on HO-1 and septic lung injury. Cecal ligation and puncture (CLP) was employed to induce septic lung injury. Mice pretreated with artesunate (AS) (15 mg/kg) exhibited decreased sepsis-induced mortality and lung injury and alleviated lung pathological changes and neutrophil infiltration. In addition, AS lowered the levels of tumor necrosis factor-α (TNF-α) and interleukin-6 (IL-6) in the serum and bronchoalveolar lavage fluid (BALF) and inhibited cyclooxygenase-2 (COX-2) and inducible nitric oxide synthase isoform (iNOS) expression and NF-κB activation in lung tissue. In addition, AS enhanced NF-E2-related factor-2 (Nrf2) activation and HO-1 expression and enzymatic activity in lung tissue. However, the protective effects of AS on sepsis-induced lung injury were eliminated by ZnPP IX, an HO-1 competitive inhibitor. Therefore, AS plays protective roles in septic lung injury related to the upregulation of HO-1. These findings suggest an effective and applicable treatment to sepsis-induced lung injury and provide new insights into the molecular mechanisms and actions of AS.
SUPPLEMENTAL MATERIAL
Coming soon ....
REFERENCES (42)
CITATIONS (54)
EXTERNAL LINKS
PlumX Metrics
RECOMMENDATIONS
FAIR ASSESSMENT
Coming soon ....
JUPYTER LAB
Coming soon ....